ESPR - Esperion Therapeutics, Inc. - SEC Form 4 Insider Trading Screener
21 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| P | 1 | +0 | -9 | -4 | +0 |
| S | 2 | -4 | -14 | -9 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-01-04 | ESPR | Biotech Target N V | 10% | P - Purchase | $41.29 | +80,000 | 3,472,964 | +2% | +$3,303,256 | ||||||
2018-12-24 | ESPR | Biotech Target N V | 10% | P - Purchase | $39.91 | +50,000 | 3,392,964 | +1% | +$1,995,725 | ||||||
2018-12-17 | ESPR | Biotech Target N V | 10% | P - Purchase | $47.73 | +60,000 | 3,342,964 | +2% | +$2,864,070 | ||||||
| M | 2018-11-02 | ESPR | Boxer Capital, LLC | 10% | S - Sale | $56.38 | -100,000 | 1,101,250 | -8% | -$5,638,343 | |||||
| M | 2018-11-01 | ESPR | Newton Roger S | Dir | S - Sale | $50.07 | -2,827 | 573,726 | 0% | -$141,549 | |||||
| M | 2018-10-16 | ESPR | Newton Roger S | Dir | S - Sale | $50.02 | -22,173 | 576,553 | -4% | -$1,108,997 | |||||
2018-08-27 | ESPR | Newton Roger S | Dir | S - Sale | $51.05 | -17,700 | 598,726 | -3% | -$903,610 | ||||||
2018-08-17 | ESPR | Newton Roger S | Dir | S - Sale | $50.06 | -7,300 | 616,426 | -1% | -$365,438 | ||||||
2018-08-03 | ESPR | Biotech Target N V | 10% | P - Purchase | $46.14 | +50,000 | 3,282,964 | +2% | +$2,306,970 | ||||||
2018-07-12 | ESPR | Biotech Target N V | 10% | P - Purchase | $41.77 | +50,000 | 3,232,964 | +2% | +$2,088,300 | ||||||
2018-06-29 | ESPR | Biotech Target N V | 10% | P - Purchase | $39.48 | +50,000 | 3,182,964 | +2% | +$1,973,805 | ||||||
2018-06-21 | ESPR | Biotech Target N V | 10% | P - Purchase | $38.57 | +60,000 | 3,132,964 | +2% | +$2,314,224 | ||||||
2018-06-07 | ESPR | Biotech Target N V | 10% | P - Purchase | $37.79 | +60,000 | 3,072,964 | +2% | +$2,267,292 | ||||||
2018-06-05 | ESPR | Biotech Target N V | 10% | P - Purchase | $38.47 | +60,000 | 3,012,964 | +2% | +$2,308,440 | ||||||
| M | 2018-05-18 | ESPR | Biotech Target N V | 10% | P - Purchase | $40.11 | +130,000 | 2,952,964 | +5% | +$5,213,770 | |||||
2018-03-29 | ESPR | Newton Roger S | Dir | S - Sale | $72.37 | -25,000 | 623,726 | -4% | -$1,809,277 | ||||||
| D | 2018-01-25 | ESPR | Vitullo Nicole | Dir | S - Sale+OE | $71.79 | -11,674 | 1,141,057 | -1% | -$838,076 | |||||
2017-12-06 | ESPR | Vitullo Nicole | Dir | S - Sale | $53.85 | -9,326 | 1,937,722 | 0% | -$502,205 | ||||||
2017-03-21 | ESPR | Janney Daniel | Dir | S - Sale | $45.80 | -350,000 | 1,366,987 | -20% | -$16,029,263 | -4 | -14 | -9 | |||
| M | 2017-03-21 | ESPR | Goldstein Dov A Md | Dir | S - Sale | $41.66 | -800,000 | 837,125 | -49% | -$33,327,088 | -4 | -14 | -9 | ||
2017-03-21 | ESPR | Omenn Gilbert S | Dir | P - Purchase | $42.26 | +1,000 | 11,000 | +10% | +$42,260 | 0 | -9 | -4 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |